Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0016020 | membrane | 2 | 6 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 3 |
GO:0031090 | organelle membrane | 3 | 3 |
Related structures:
AlphaFold database: Q4QEY6
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 6 |
GO:0006694 | steroid biosynthetic process | 5 | 2 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0008202 | steroid metabolic process | 4 | 6 |
GO:0008610 | lipid biosynthetic process | 4 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0016125 | sterol metabolic process | 4 | 6 |
GO:0016126 | sterol biosynthetic process | 5 | 2 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 6 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 6 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000247 | C-8 sterol isomerase activity | 5 | 2 |
GO:0003824 | catalytic activity | 1 | 6 |
GO:0004769 | steroid delta-isomerase activity | 5 | 2 |
GO:0016853 | isomerase activity | 2 | 6 |
GO:0016860 | intramolecular oxidoreductase activity | 3 | 6 |
GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds | 4 | 6 |
GO:0047750 | cholestenol delta-isomerase activity | 5 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 21 | 25 | PF00656 | 0.257 |
CLV_NRD_NRD_1 | 154 | 156 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.441 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.384 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.362 |
CLV_PCSK_PC7_1 | 155 | 161 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.208 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.347 |
DOC_CDC14_PxL_1 | 92 | 100 | PF14671 | 0.250 |
DOC_CYCLIN_yCln2_LP_2 | 126 | 132 | PF00134 | 0.294 |
DOC_MAPK_gen_1 | 159 | 165 | PF00069 | 0.544 |
DOC_MAPK_MEF2A_6 | 50 | 57 | PF00069 | 0.241 |
DOC_PP2B_LxvP_1 | 126 | 129 | PF13499 | 0.241 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.250 |
LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.579 |
LIG_14-3-3_CanoR_1 | 26 | 34 | PF00244 | 0.358 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.436 |
LIG_FHA_2 | 19 | 25 | PF00498 | 0.257 |
LIG_LIR_Gen_1 | 17 | 28 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 72 | 81 | PF02991 | 0.241 |
LIG_LIR_Nem_3 | 136 | 140 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.324 |
LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.245 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.244 |
LIG_Pex14_2 | 112 | 116 | PF04695 | 0.257 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.241 |
LIG_SH2_NCK_1 | 20 | 24 | PF00017 | 0.312 |
LIG_SH2_PTP2 | 137 | 140 | PF00017 | 0.496 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.335 |
LIG_SH2_STAT3 | 86 | 89 | PF00017 | 0.241 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.251 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.279 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.258 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.255 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.321 |
LIG_SH3_3 | 60 | 66 | PF00018 | 0.529 |
LIG_SUMO_SIM_par_1 | 40 | 46 | PF11976 | 0.241 |
LIG_TRFH_1 | 125 | 129 | PF08558 | 0.294 |
LIG_TYR_ITIM | 123 | 128 | PF00017 | 0.224 |
LIG_UBA3_1 | 44 | 50 | PF00899 | 0.241 |
LIG_WRC_WIRS_1 | 31 | 36 | PF05994 | 0.310 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.615 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.241 |
MOD_Cter_Amidation | 157 | 160 | PF01082 | 0.361 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.403 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.509 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.450 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.369 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.388 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.463 |
MOD_N-GLC_1 | 34 | 39 | PF02516 | 0.562 |
MOD_N-GLC_2 | 142 | 144 | PF02516 | 0.325 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.282 |
MOD_PIKK_1 | 75 | 81 | PF00454 | 0.298 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.581 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.250 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.307 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.241 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.250 |
TRG_DiLeu_BaLyEn_6 | 11 | 16 | PF01217 | 0.316 |
TRG_ENDOCYTIC_2 | 113 | 116 | PF00928 | 0.241 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.241 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.279 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.494 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.271 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JDK8 | Bodo saltans | 67% | 70% |
A0A1X0NZ45 | Trypanosomatidae | 63% | 70% |
A4HWT3 | Leishmania infantum | 92% | 100% |
E9AQJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q15125 | Homo sapiens | 32% | 73% |